Regulation of energy homeostasis by the NPY system

Trends in Endocrinology and Metabolism

Volumn 26, Issue 3, 2015, Pages 125-135

  Loh, Kim ^a,b   Herzog, Herbert ^a,b   Shi, Yan Chuan ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Energy expenditure; Energy homeostasis; Neuropeptide Y (NPY); Pancreatic polypeptide (PP); Peptide YY (PYY)

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; NEUROPEPTIDE Y6 RECEPTOR; PANCREAS POLYPEPTIDE; PEPTIDE YY; UNCLASSIFIED DRUG;

ENERGY BALANCE; ENERGY EXPENDITURE; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; CALORIC INTAKE; ENERGY METABOLISM; METABOLISM; OBESITY; PHYSIOLOGY;

ENERGY INTAKE; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; NEUROPEPTIDE Y; OBESITY; PEPTIDE YY;

EID: 84923338353     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.01.003     Document Type: Review

References (106)

1. Stephens M., et al. Brown fat and obesity: the next big thing?. Clin. Endocrinol. (Oxf.) 2011, 74:661-670.
2. Morton G.J., et al. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
3. Baraban S.C. Neuropeptide Y and limbic seizures. Rev. Neurosci. 1998, 9:117-128.
4. 125I]-PYY binding in Y receptor knockout mice suggest the potential existence of further Y receptor(s). Neuropeptides 2005, 39:21-28.
5. Lin S., et al. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 2004, 38:189-200.
6. Schutz B., et al. VIP and NPY expression during differentiation of cholinergic and noradrenergic sympathetic neurons. Ann. N. Y. Acad. Sci. 1998, 865:537-541.
7. Baldock P.A., et al. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J. Biol. Chem. 2007, 282:19092-19102.
8. Yang K., et al. Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor. FASEB J. 2008, 22:2452-2464.
9. Ekblad E., Sundler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 2002, 23:251-261.
10. Adrian T.E. Pancreatic polypeptide. J. Clin. Pathol. Suppl. (Assoc. Clin. Pathol.) 1978, 8:43-50.
11. Blomqvist A.G., Herzog H. Y-receptor subtypes - how many more?. Trends Neurosci. 1997, 20:294-298.
12. Yulyaningsih E., et al. Pancreatic polypeptide controls energy homeostasis via Npy6r signaling in the suprachiasmatic nucleus in mice. Cell Metab. 2014, 19:58-72.
13. Kassis S., et al. Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein. J. Biol. Chem. 1987, 262:3429-3431.
14. Parker R., Herzog H. Localization of Y-receptor subtype mRNAs in rat brain by digoxigenin labeled in situ hybridization. Methods Mol. Biol. 2000, 153:165-183.
15. Wheway J., et al. The Y1 receptor for NPY: a key modulator of the adaptive immune system. Peptides 2007, 28:453-458.
16. Zhang L., et al. Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion. Int. J. Obes. (Lond.) 2010, 34:357-373.
17. Shi Y.C., et al. Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity. Obesity (Silver Spring) 2011, 19:2137-2148.
18. Parker R.M., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 1999, 11:1431-1448.
19. Yulyaningsih E., et al. NPY receptors as potential targets for anti-obesity drug development. Br. J. Pharmacol. 2011, 163:1170-1202.
20. Naveilhan P., et al. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience 1998, 87:289-302.
21. Herzog H., et al. Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation. Genomics 1997, 41:315-319.
22. Burkhoff A., et al. Distribution of a novel hypothalamic neuropeptide Y receptor gene and it's absence in rat. Brain Res. Mol. Brain Res. 1998, 53:311-316.
23. Gregor P., et al. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J. Biol. Chem. 1996, 271:27776-27781.
24. Matsumoto M., et al. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J. Biol. Chem. 1996, 271:27217-27220.
25. Weinberg D.H., et al. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. 1996, 271:16435-16438.
26. Hahn T.M., et al. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1998, 1:271-272.
27. Acuna-Goycolea C., et al. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J. Neurosci. 2005, 25:7406-7419.
28. Ellacott K.L., Cone R.D. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog. Horm. Res. 2004, 59:395-408.
29. Luquet S., et al. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 2005, 310:683-685.
30. Dowell P., et al. Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. Annu. Rev. Biochem. 2005, 74:515-534.
31. Zhang Y., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
32. Schwartz M.W., et al. Central nervous system control of food intake. Nature 2000, 404:661-671.
33. Ahima R.S., et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996, 382:250-252.
34. Schwartz M.W., et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 1992, 130:3608-3616.
35. Asakawa A., et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001, 120:337-345.
36. Kamegai J., et al. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000, 141:4797-4800.
37. Bell C.G., et al. The genetics of human obesity. Nat. Rev. Genet. 2005, 6:221-234.
38. Atasoy D., et al. Deconstruction of a neural circuit for hunger. Nature 2012, 488:172-177.
39. Erickson J.C., et al. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996, 274:1704-1707.
40. Qian S., et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell. Biol. 2002, 22:5027-5035.
41. Wu Q., Palmiter R.D. GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism. Eur. J. Pharmacol. 2011, 660:21-27.
42. Wu Q., et al. Deciphering a neuronal circuit that mediates appetite. Nature 2012, 483:594-597.
43. Shi Y.C., et al. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab. 2013, 17:236-248.
44. Sainsbury A., Zhang L. Role of the arcuate nucleus of the hypothalamus in regulation of body weight during energy deficit. Mol. Cell. Endocrinol. 2010, 316:109-119.
45. Sainsbury A., et al. Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes 1997, 46:209-214.
46. Billington C.J., et al. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am. J. Physiol. 1994, 266:R1765-R1770.
47. Kuo L.E., et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 2007, 13:803-811.
48. Bi S., Li L. Browning of white adipose tissue: role of hypothalamic signaling. Ann. N. Y. Acad. Sci. 2013, 1302:30-34.
49. Chao P.T., et al. Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity. Cell Metab. 2011, 13:573-583.
50. Zhang L., et al. The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer. Pharmacol. Ther. 2011, 131:91-113.
51. Mullins D., et al. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo. Mol. Pharmacol. 2001, 60:534-540.
52. Henry M., et al. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors. Obes. Res. 2005, 13:36-47.
53. Kushi A., et al. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15659-15664.
54. Pedrazzini T., et al. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat. Med. 1998, 4:722-726.
55. Kanatani A., et al. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 2000, 141:1011-1016.
56. Pralong F.P., et al. The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. FASEB J. 2002, 16:712-714.
57. Karl T., et al. Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety. Behav. Brain Res. 2006, 167:87-93.
58. Karl T., et al. Y1 receptors regulate aggressive behavior by modulating serotonin pathways. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:12742-12747.
59. Sainsbury A., et al. Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice. Diabetes 2006, 55:19-26.
60. Gan S.K., et al. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes. Res. 2003, 11:1295-1305.
61. Sitticharoon C., et al. Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors. Regul. Pept. 2013, 185:65-72.
62. Serradeil-Le Gal C., et al. Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes. FEBS Lett. 2000, 475:150-156.
63. Han R., et al. Stress hormone epinephrine enhances adipogenesis in murine embryonic stem cells by up-regulating the neuropeptide Y system. PLoS ONE 2012, 7:e36609.
64. Wieland H.A., et al. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br. J. Pharmacol. 1998, 125:549-555.
65. Sousa D.M., et al. Neuropeptide Y Y1 receptor antagonism increases bone mass in mice. Bone 2012, 51:8-16.
66. Lee N.J., et al. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity. J. Bone Miner. Res. 2010, 25:1736-1747.
67. Shi Y.C., Baldock P.A. Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue. Bone 2012, 50:430-436.
68. Broberger C., et al. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 1997, 66:393-408.
69. 3-36 physiologically inhibits food intake. Nature 2002, 418:650-654.
70. 3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice. Obesity (Silver Spring) 2013, 21:E669-E678.
71. Shi Y.C., et al. NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice. PLoS ONE 2010, 5:e11361.
72. Stanic D., et al. Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules. J. Comp. Neurol. 2011, 519:1219-1257.
73. 3-36 into the arcuate nucleus inhibits food deprivation-induced increases in food hoarding and intake. Peptides 2013, 47:20-28.
74. 3-36 produces conditioned taste aversion in mice. Cell Metab. 2005, 1:159-168.
75. La Sala M.S., et al. Modulation of taste responsiveness by the satiation hormone peptide YY. FASEB J. 2013, 27:5022-5033.
76. Hurtado M.D., et al. Salivary peptide tyrosine-tyrosine 3-36 modulates ingestive behavior without inducing taste aversion. J. Neurosci. 2013, 33:18368-18380.
77. Hurtado M.D., et al. Distribution of Y-receptors in murine lingual epithelia. PLoS ONE 2012, 7:e46358.
78. Acosta A., et al. Salivary PYY: a putative bypass to satiety. PLoS ONE 2011, 6:e26137.
79. Rosmaninho-Salgado J., et al. Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression. Peptides 2012, 37:49-54.
80. Sainsbury A., et al. Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev. 2002, 16:1077-1088.
81. Lin S., et al. Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice. PLoS ONE 2009, 4:e8488.
82. McTigue D.M., et al. Effect of pancreatic polypeptide on rat dorsal vagal complex neurons. J. Physiol. 1997, 499:475-483.
83. Ueno N., et al. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 1999, 117:1427-1432.
84. Asakawa A., et al. Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptides 1999, 20:1445-1448.
85. Asakawa A., et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003, 124:1325-1336.
86. 32-36: development of an anorectic Y4 receptor selective agonist with picomolar affinity. J. Med. Chem. 2006, 49:2661-2665.
87. Sainsbury A., et al. Y4 receptors and pancreatic polypeptide regulate food intake via hypothalamic orexin and brain-derived neurotropic factor dependent pathways. Neuropeptides 2010, 44:261-268.
88. Sainsbury A., et al. Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Mol. Cell. Biol. 2003, 23:5225-5233.
89. Lee N.J., et al. Synergistic attenuation of obesity by Y2- and Y4-receptor double knockout in ob/ob mice. Nutrition 2008, 24:892-899.
90. DiMaggio D.A., et al. Pancreatic polypeptide immunoreactivity in rat brain is actually neuropeptide Y. Neuroscience 1985, 15:1149-1157.
91. Mounzih K., et al. Leptin treatment rescues the sterility of genetically obese ob/ob males. Endocrinology 1997, 138:1190-1193.
92. Tough I.R., et al. Y(4) receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa. J. Pharmacol. Exp. Ther. 2006, 319:20-30.
93. 2+ signaling in nodose ganglion neurons. Neuropeptides 2013, 47:19-23.
94. Batterham R.L., et al. Pancreatic polypeptide reduces appetite and food intake in humans. J. Clin. Endocrinol. Metab. 2003, 88:3989-3992.
95. Jesudason D.R., et al. Low-dose pancreatic polypeptide inhibits food intake in man. Br. J. Nutr. 2007, 97:426-429.
96. Gerald C., et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996, 382:168-171.
97. Marsh D.J., et al. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat. Med. 1998, 4:718-721.
98. Cabrele C., Beck-Sickinger A.G. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J. Pept. Sci. 2000, 6:97-122.
99. McCrea K., et al. 2-36[K4,RYYSA(19-23)]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake. Regul. Pept. 2000, 87:47-58.
100. Nguyen A.D., et al. Y1 and Y5 receptors are both required for the regulation of food intake and energy homeostasis in mice. PLoS ONE 2012, 7:e40191.
101. Mashiko S., et al. Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. Eur. J. Pharmacol. 2009, 615:113-117.
102. Asnicar M.A., et al. Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate. Endocrinology 2002, 143:3994-4006.
103. Niewiadomski P., et al. Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death. J. Mol. Neurosci. 2008, 36:200-207.
104. Aton S.J., et al. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat. Neurosci. 2005, 8:476-483.
105. Brown T.M., et al. Disrupted neuronal activity rhythms in the suprachiasmatic nuclei of vasoactive intestinal polypeptide-deficient mice. J. Neurophysiol. 2007, 97:2553-2558.
106. Mullins D.E., et al. Pharmacological characterization of the cloned neuropeptide Y y(6) receptor. Eur. J. Pharmacol. 2000, 395:87-93.